| CPC G16C 20/20 (2019.02) [G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 50/80 (2018.01)] | 13 Claims |
|
1. A molecular signature detection system comprising:
a first subsystem is an electronic device comprising a central processing unit (CPU) and a database of molecular signatures, wherein the CPU processes a lookup and matching of a molecular signature sampled and detected by an electronic nose to identify whether there is a match with a molecular signature stored in the database, the molecular signature indicating presence of an odor associated with molecular fingerprints of COVID-19 and variant strains, viruses, bacteria, pathogens, microorganisms, dysfunctional disorders having a molecular signature, cancers by type, explosives, illegal drugs, and/or substances with a detectable odor;
a second subsystem comprising a sanitation circuit including Ultraviolet C (UVC) (290 nm-100 nm) or Ultraviolet B (UVB) (320 nm-290 nm) radiation bulbs capable of sanitizing and/or deactivating outflow air to prevent false positive readings from air samples passing through the sanitation circuit or from ambient air;
a third subsystem comprising the electronic nose that samples intake air samples and passes detected molecular signatures through to the second subsystem to be processed by the CPU to look up and match against molecular signatures stored in the database in the first subsystem;
a fourth subsystem comprising a tube that intakes odorous air from breath and/or body odors of an individual, chemical, organism, or substance and transmits the intake air to the electronic nose in the third subsystem for sampling; and
a fifth subsystem comprising an external power supply, a battery, a redundant battery, and one or more communications ports, wherein the fifth subsystem powers at least the first subsystem and the third subsystem,
wherein the first subsystem has an alert system that provides a visual indication on the first subsystem whether the individual is safe to pass when there is no match in the database or should be stopped when there is a match in the database, and
wherein each of the molecular signatures in the database are identified by gas chromatography before being entered in the database.
|